Generian Achieves First Milestones in Mitobridge Collaboration

PITTSBURGH and CAMBRIDGE, Mass., Feb. 8, 2023 /PRNewswire/ — Generian Pharmaceuticals, Inc., a preclinical biopharmaceutical company discovering and developing first-in-class orally bioavailable small molecule therapeutics, announced today that it has achieved the first research…

About the Author

has written 41546 stories on this site.

Copyright © 2010 Business and Corporate News.